Sales decline 6.00% to Rs 1510.93 crore
Net profit of Glenmark Pharmaceuticals declined 47.80% to Rs 270.84 crore in the quarter ended June 2017 as against Rs 518.81 crore during the previous quarter ended June 2016. Sales declined 6.00% to Rs 1510.93 crore in the quarter ended June 2017 as against Rs 1607.35 crore during the previous quarter ended June 2016. ParticularsQuarter EndedJun. 2017Jun. 2016% Var.Sales1510.931607.35 -6 OPM %23.3637.39 -PBDT349.79687.80 -49 PBT319.85662.32 -52 NP270.84518.81 -48Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
